相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice
Chun-Wei Chen et al.
VACCINES (2023)
Comparison of Bacterial Expression Systems Based on Potato Virus Y-like Particles for Vaccine Generation
Anete Ogrina et al.
VACCINES (2022)
Cross-protection against African swine fever virus upon intranasal vaccination is associated with an adaptive-innate immune crosstalk
Laia Bosch-Camos et al.
PLOS PATHOGENS (2022)
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Hao Sun et al.
BIOMARKER RESEARCH (2022)
Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in Mice
Nayoung Kim et al.
VACCINES (2022)
The impact of size on particle drainage dynamics and antibody response
Simon Zinkhan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus
Lo Vang et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
P22 virus-like particles as an effective antigen delivery nanoplatform for cancer immunotherapy
Wenjing Li et al.
BIOMATERIALS (2021)
Biological Characterization of Hepatitis B virus Genotypes: Their Role in Viral Replication and Antigen Expression
Maria Mercedes Elizalde et al.
FRONTIERS IN MICROBIOLOGY (2021)
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward et al.
NATURE MEDICINE (2021)
Establishment of a piscine myocarditis virus (PMCV) challenge model and testing of a plant-produced subunit vaccine candidate against cardiomyopathy syndrome (CMS) in Atlantic salmon Salmo salar
Hang Su et al.
AQUACULTURE (2021)
A Plant-Produced Virus-Like Particle Displaying Envelope Protein Domain III Elicits an Immune Response Against West Nile Virus in Mice
Jennifer Stander et al.
FRONTIERS IN PLANT SCIENCE (2021)
Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease
Yoichi Nakahira et al.
FRONTIERS IN PLANT SCIENCE (2021)
Development of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine
He Hu et al.
CANCERS (2021)
Chimeric VLPs Bearing VP60 from Two Serotypes of Rabbit Haemorrhagic Disease Virus Are Protective against Both Viruses
Kevin P. Dalton et al.
VACCINES (2021)
Efficacy of a plant-produced virus-like particle vaccine in chickens challenged with Influenza A H6N2 virus
Tanja Smith et al.
PLANT BIOTECHNOLOGY JOURNAL (2020)
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial
Sabrina H. Tsang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
A Chimeric Sudan Virus-Like Particle Vaccine Candidate Produced by a Recombinant Baculovirus System Induces Specific Immune Responses in Mice and Horses
Fangfang Wu et al.
VIRUSES-BASEL (2020)
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
Joan Kha-Tu Ho et al.
VIRUSES-BASEL (2020)
HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh
K. Zaman et al.
BMJ OPEN (2020)
Mosquito Cell-Derived Japanese Encephalitis Virus-Like Particles Induce Specific Humoral and Cellular Immune Responses in Mice
Yu-Hsiu Chang et al.
VIRUSES-BASEL (2020)
The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines
Darren Z. L. Mok et al.
VIRUSES-BASEL (2020)
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency
Anna Czarnota et al.
VACCINES (2020)
Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans
Gui-Ping Wen et al.
NATURE COMMUNICATIONS (2020)
Cross-Protection of Hepatitis B Vaccination among Different Genotypes
Takako Inoue et al.
VACCINES (2020)
Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries
Susanne K. Kjaer et al.
ECLINICALMEDICINE (2020)
Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer
Lukai Zhai et al.
ANTIVIRAL RESEARCH (2019)
Immunogenicity of plant-produced porcine circovirus-like particles in mice
Cornelius J. Gunter et al.
PLANT BIOTECHNOLOGY JOURNAL (2019)
Newcastle disease virus-like particles containing the Brucella BCSP31 protein induce dendritic cell activation and protect mice against virulent Brucella challenge
Xiaohong Xu et al.
VETERINARY MICROBIOLOGY (2019)
Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice
Melek M. E. Sunay et al.
VACCINE (2019)
Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years
Xu-ya Yu et al.
VACCINE (2019)
Qβ Virus-like particle-based vaccine induces robust immunity and protects against tauopathy
Nicole M. Maphis et al.
NPJ VACCINES (2019)
Plant-Made Nervous Necrosis Virus-Like Particles Protect Fish Against Disease
Johanna Marsian et al.
FRONTIERS IN PLANT SCIENCE (2019)
Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies
Sophie Buffin et al.
VACCINE (2019)
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Daria A. Rutkowska et al.
BMC VETERINARY RESEARCH (2019)
Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine
Susan J. Dennis et al.
PLANT BIOTECHNOLOGY JOURNAL (2018)
Hepatitis E virus genotypes and subgenotypes causing acute hepatitis, Bulgaria, 2013-2015
Roberto Bruni et al.
PLOS ONE (2018)
Classification and Genomic Diversity of Enterically Transmitted Hepatitis Viruses
Donald B. Smith et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice
Viswanathan Ramasamy et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses
Jing Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults
Jessica A. Chichester et al.
VACCINE (2018)
A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries
Susanne K. Kjaer et al.
CLINICAL INFECTIOUS DISEASES (2018)
Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
Susan J. Dennis et al.
VETERINARY RESEARCH (2018)
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial
Warner K. Huh et al.
LANCET (2017)
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Seth J. Zost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity
Huirong Pan et al.
VACCINE (2017)
Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease
Rhiannon R. Penkert et al.
VACCINE (2017)
Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens
Peter Pushko et al.
VIROLOGY (2017)
The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses An Individual Participant Meta-analysis
Merryn Voysey et al.
JAMA PEDIATRICS (2017)
Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy
Andris Zeltins et al.
NPJ VACCINES (2017)
A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model
Pramila Walpita et al.
NPJ VACCINES (2017)
A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9
Lukai Zhai et al.
ANTIVIRAL RESEARCH (2017)
Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs
Xinsheng Liu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine
Sasirekha Ramani et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Porcine parvovirus capsid protein expressed in Escherichia coli self assembles into virus-like particles with high immunogenicity in mice and guinea pigs
Pengchao Ji et al.
ANTIVIRAL RESEARCH (2017)
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
Chong Wang et al.
ANTIVIRAL RESEARCH (2017)
Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models
Che-Ming Jack Hu et al.
BMC BIOTECHNOLOGY (2017)
Different Applications of Virus-Like Particles in Biology and Medicine: Vaccination and Delivery Systems
Zeinab Shirbaghaee et al.
BIOPOLYMERS (2016)
Immunogenicity difference between two hepatitis E vaccines derived from genotype 1 and 4
Jiyue Wen et al.
ANTIVIRAL RESEARCH (2016)
Gardasil-9: A global survey of projected efficacy
Lukai Zhai et al.
ANTIVIRAL RESEARCH (2016)
The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines
Michael J. McCluskie et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2016)
The True Story and Advantages of RNA Phage Capsids as Nanotools
Paul Pumpens et al.
INTERVIROLOGY (2016)
An optimized, highly efficient, self-assembled, subvirus-like particle of infectious bursal disease virus (IBDV)
Miao Wang et al.
VACCINE (2016)
Induction of mucosal immunity through systemic immunization: Phantom or reality?
Fei Su et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate
Shweta Saraswat et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza
Veronika I. Zarnitsyna et al.
PLOS PATHOGENS (2016)
Coupling Peptide Antigens to Virus-Like Particles or to Protein Carriers Influences the Th1/Th2 Polarity of the Resulting Immune Response
Rattanaruji Pomwised et al.
VACCINES (2016)
African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014
Camilla T. Weyer et al.
EMERGING INFECTIOUS DISEASES (2016)
The application of virus-like particles as vaccines and biological vehicles
Dan Yan et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
E. A. Joura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long-Term Efficacy of a Hepatitis E Vaccine
Jun Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection
Susumu Hamada-Tsutsumi et al.
PLOS ONE (2015)
A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice
Liping Jiang et al.
VACCINE (2015)
Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate
Diego Fontana et al.
VACCINE (2015)
Hepatitis B Virus Epidemiology
Jennifer H. MacLachlan et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Durability of Antibody Response Against Hepatitis B Virus in Healthcare Workers Vaccinated as Adults
Naveen Gara et al.
CLINICAL INFECTIOUS DISEASES (2015)
Structural Basis for the Development of Avian Virus Capsids That Display Influenza Virus Proteins and Induce Protective Immunity
Elena Pascual et al.
JOURNAL OF VIROLOGY (2015)
Comparison of the Immunogenicity and Reactogenicity of Cervarix and Gardasil Human Papillomavirus Vaccines in HIV-Infected Adults: A Randomized, Double-Blind Clinical Trial
Lars Toft et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial
Lee-Jah Chang et al.
LANCET (2014)
Rabies virus-like particles expressed in HEK293 cells
Diego Fontana et al.
VACCINE (2014)
Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice
Hui Zhao et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2013)
Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
Christina Schellenbacher et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles
Eva C. Thuenemann et al.
PLANT BIOTECHNOLOGY JOURNAL (2013)
M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A
Lorena Itati Ibanez et al.
PLOS ONE (2013)
Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
Shailendra Mani et al.
PLOS ONE (2013)
A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice
R. Mark Jones et al.
PLOS ONE (2013)
A Novel M2e Based Flu Vaccine Formulation for Dogs
Denis Leclerc et al.
PLOS ONE (2013)
Chromatographically-purified capsid proteins of red-spotted grouper nervous necrosis virus expressed in Saccharomyces cerevisiae form virus-like particles
Yoo Ri Choi et al.
PROTEIN EXPRESSION AND PURIFICATION (2013)
Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice
Hao-Yang Li et al.
VACCINE (2013)
Virus-like particle vaccine protects against H3N2 canine influenza virus in dog
Dong-Hun Lee et al.
VACCINE (2013)
A universal virus-like particle-based vaccine for human papillomavirus: Longevity of protection and role of endogenous and exogenous adjuvants
Ebenezer Tumban et al.
VACCINE (2013)
Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease
Huifang Shen et al.
VIRUS RESEARCH (2013)
Virus-induced humoral immunity: on how B cell responses are initiated
Franziska Zabel et al.
CURRENT OPINION IN VIROLOGY (2013)
Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector
Marlyse C. Knuchel et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
Stefan W. Metz et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
How B cells capture, process and present antigens: a crucial role for cell polarity
Maria-Isabel Yuseff et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Immunological Response to Parenteral Vaccination with Recombinant Hepatitis B Virus Surface Antigen Virus-Like Particles Expressing Helicobacter pylori KatA Epitopes in a Murine H. pylori Challenge Model
Michael Kotiw et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Potato Virus Y-Like Particles as a New Carrier for the Presentation of Foreign Protein Stretches
Ieva Kalnciema et al.
MOLECULAR BIOTECHNOLOGY (2012)
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Cosette M. Wheeler et al.
LANCET ONCOLOGY (2012)
VLPs Displaying a Single L2 Epitope Induce Broadly Cross-Neutralizing Antibodies against Human Papillomavirus
Ebenezer Tumban et al.
PLOS ONE (2012)
Merck Ad5/HIV induces broad innate immune activation that predicts CD8+ T-cell responses but is attenuated by preexisting Ad5 immunity
Daniel E. Zak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Chimeric calicivirus-like particles elicit specific immune responses in pigs
E. Crisci et al.
VACCINE (2012)
Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice
Baoying Huang et al.
VIROLOGY JOURNAL (2012)
A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2
Ebenezer Tumban et al.
PLOS ONE (2011)
Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants
Yang YanMei et al.
SCIENCE CHINA-LIFE SCIENCES (2011)
Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine
Zhang XiZhen et al.
SCIENCE CHINA-LIFE SCIENCES (2011)
Safety and immunogenicity of a candidate parvovirus B19 vaccine
David I. Bernstein et al.
VACCINE (2011)
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
Feng-Cai Zhu et al.
LANCET (2010)
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
Wataru Akahata et al.
NATURE MEDICINE (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16-26 Years
Cosette M. Wheeler et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years
Darron R. Brown et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
A Trivalent Virus-Like Particle Vaccine Elicits Protective Immune Responses against Seasonal Influenza Strains in Mice and Ferrets
Ted M. Ross et al.
PLOS ONE (2009)
Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein
Paola Di Bonito et al.
VIROLOGY (2009)
Recognition of viral single-stranded RNA by Toll-like receptors
Sandra S. Diebold
ADVANCED DRUG DELIVERY REVIEWS (2008)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor Transgenic mouse model
Bryce Chackerian et al.
JOURNAL OF IMMUNOLOGY (2008)
Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes
Kazunari Kondo et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Antibodies from women immunized with Gardasil® cross-neutralize HPV 45 pseudovirions
Judith F. Smith et al.
HUMAN VACCINES (2007)
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization
Jerome Denis et al.
VIROLOGY (2007)
Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts
Ming Xia et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests
Anja Zielonka et al.
VIRUS RESEARCH (2006)
Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes
Kenneth E. Palmer et al.
VACCINE (2006)
Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation
L Buonaguro et al.
JOURNAL OF VIROLOGY (2005)
A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates
SW Li et al.
VACCINE (2005)
Recognition of single-stranded RNA viruses by Toll-like receptor 7
JM Lund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16
A Varsani et al.
JOURNAL OF VIROLOGY (2003)
Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A
L Buonaguro et al.
ANTIVIRAL RESEARCH (2002)
分享论文
